Did you know?

Valuation metrics show that Synlogic, Inc. may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of SYBX ...Find real-time ARTL - Artelo Biosciences Inc stock quotes, company profile, news and forecasts from CNN Business.Track Synlogic Inc (SYBX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Dec 1, 2023 · SYBX's stock price has decreased by -75.27% in the past year and price targets may not have had time to catch up. Stock Price Forecast According to 2 stock analysts, the average 12-month stock price forecast for Synlogic stock is $82.5, which predicts an increase of 3,122.66%. Stock Price Forecast. The 3 analysts offering 12-month price forecasts for GeoVax Labs Inc have a median target of 6.00, with a high estimate of 8.00 and a low estimate of 4.00. The median ...GOVX Stock 12 Months Forecast. $8.00. (1542.54% Upside) Based on 1 Wall Street analysts offering 12 month price targets for GeoVax Labs in the last 3 months. The average price target is $8.00 with a high forecast of $8.00 and a low forecast of $8.00. The average price target represents a 1542.54% change from the last price of $0.49.Synlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche Collaboration. CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious …SYBX stock forecast Our latest prediction for Synlogic Inc's stock price was made on the April 6, 2023 when the stock price was at 0.58$. In the short term (2weeks), SYBX's stock price should underperform the market by -1.40%. During that period the price should oscillate between -12.02% and +11.61% ...APTO Stock 12 Months Forecast. $15.83. (471.48% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Aptose Biosciences in the last 3 months. The average price target is $15.83 with a high forecast of $23.00 and a low forecast of $12.00. The average price target represents a 471.48% change from the last price of $2.77.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Golden Grail Technology share forecasts, stock quote and buy / sell signals below. According to present data Golden Grail Technology's GOGY shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Synlogic (NASDAQ:SYBX) is undoubtedly a potential 10X investment, judging by its numbers alone.Shares of SYBX stock trade at only 53 cents per share, while its target stock price is $7.17.So, it ...The 2 analysts offering 1 year price forecasts for SYBX have a max estimate of — and a min estimate of —. Analyst rating Based on 3 analysts giving stock ratings to SYBX in the past 3 months.The average price target for Microvast Holdings is $8.00. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $8.00 ,the lowest forecast is $8.00. The average price target represents 545.16% Increase from the current price of $1.24.Synlogic Stock Forecast, "SYBX" Share Price Prediction Charts Is "Synlogic Inc" a Good Investment? Current price today: 2.000 USD (+0.000001%) History Forecast Data …Another stock from the Zacks Medical - Biomedical and Genetics industry, Stoke Therapeutics, Inc. (STOK), is soon expected to post loss of $0.70 per share for the quarter ended March 2023.Stock Price Forecast. The 3 analysts offering 12-month price forecasts for Artelo Biosciences Inc have a median target of 5.00, with a high estimate of 40.00 and a low estimate of 5.00. The median ...The average Payoneer Global stock price prediction forecasts a potential upside of 43.65% from the current PAYO share price of $5.40. What is PAYO's forecast return on equity (ROE) for 2023-2025? (NASDAQ: PAYO) forecast ROE is N/A, which is considered weak.OPRA Stock 12 Months Forecast. $21.33. (84.20% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Opera in the last 3 months. The average price target is $21.33 with a high forecast of $23.00 and a low forecast of $19.00. The average price target represents a 84.20% change from the last price of $11.58. OPRA Stock 12 Months Forecast. $21.33. (84.20% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Opera in the last 3 months. The average price target is $21.33 with a high forecast of $23.00 and a low forecast of $19.00. The average price target represents a 84.20% change from the last price of $11.58. Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report. Synlogic, Inc. (SYBX) : Free Stock Analysis Report. Amicus Therapeutics, Inc. (FOLD) : Free Stock ...If you're looking for stocks that are quantitatively similar to PIERIS PHARMACEUTICALS INC, a group of peers worth examining would be SYBX, SEEL, SPRB, STTK, ...Another stock from the Zacks Medical - Biomedical and Genetics industry, Stoke Therapeutics, Inc. (STOK), is soon expected to post loss of $0.70 per share for the quarter ended March 2023.Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Cineverse Corp have a median target of 7.75, with a high estimate of 9.00 and a low estimate of 6.50. The median estimate ... Execute your SYBX trade: Decide if you will purchase ; SYBX shares at the current market price or use a limit order to buy SYBX stock at a particular price.Get the latest scoop on your SYBX position: ... Out of . 2 Wall Street analysts who give forecasts on SYBX, the consensus analyst rating on SYBX is a Strong BuyFind real-time GOVX - GeoVax Labs Inc stock quotNov 27, 2023 · According to the issued ratings of 2 analysts in the l BigBear.ai Holdings, Inc. (NYSE:BBAI) released its quarterly earnings data on Tuesday, November, 7th. The company reported $0.03 EPS for the quarter, beating the consensus estimate of ($0.07) by $0.10. The firm had revenue of $33.99 million for the quarter, compared to analyst estimates of $41.74 million. If you’re just getting started, tracking investments BBAI recently reported in-line sales and EBITDA for Q4. However, its full-year revenue outlook came in below Street’s estimates. The company expects its 2023 revenues to be in the range of $155 ... Apr 4, 2023 · The company expects its 2023 rev

The average Humana stock price prediction forecasts a potential upside of 14.35% from the current HUM share price of $510.71. What is HUM's forecast return on equity (ROE) for 2023-2026? (NYSE: HUM) forecast ROE is N/A, which is considered weak.Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buySYBX | Complete Synlogic Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.The average price target for Verrica Pharmaceuticals is $12.25. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $15.00 ,the lowest forecast is $8.00. The average price target represents 253.03% Increase from the current price of $3.47.

The average Onconova Therapeutics stock price prediction forecasts a potential upside of 1,589.71% from the current ONTX share price of $0.65. What is ONTX's forecast return on assets (ROA) for 2023-2024?CABA Stock 12 Months Forecast. $29.80. (86.25% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Cabaletta Bio in the last 3 months. The average price target is $29.80 with a high forecast of $40.00 and a low forecast of $17.00. The average price target represents a 86.25% change from the last price of $16.00.OPRA Stock 12 Months Forecast. $21.33. (84.20% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Opera in the last 3 months. The average price target is $21.33 with a high forecast of $23.00 and a low forecast of $19.00. The average price target represents a 84.20% change from the last price of $11.58.…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. NSD:SYBX Detailed Stock Analysis, Stock Price Forec. Possible cause: Stocks Synlogic Inc Synlogic Inc SYBX Morningstar Rating Stock XNAS Rating as of.